These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 577982)

  • 1. Immunotherapy with transfer factor.
    Kirkpatrick CH
    JAMA; 1977 Aug; 238(8):891. PubMed ID: 577982
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of Bechçet's syndrome with transfer factor.
    Wolf RE; Fudenberg HH; Welch TM; Spitler LE; Ziff M
    JAMA; 1977 Aug; 238(8):869-71. PubMed ID: 577975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behcet's disease: pitfalls in therapy and diagnosis.
    Freiberger HF; Fudenberg HH
    Hosp Pract; 1980 Nov; 15(11):40g-40j. PubMed ID: 7439910
    [No Abstract]   [Full Text] [Related]  

  • 4. Transfer factor II: results of therapy.
    Spitler LE; Levin AS; Fudenberg HH
    Birth Defects Orig Artic Ser; 1975; 11(1):449-56. PubMed ID: 1096990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behçet syndrome: report of two early-onset cases treated with transfer factor.
    Franzoni E; Masi M; Conte R; Giovannini A; Malferrari C; Scanabissi E; Specchia F; Ricci G
    Ital J Neurol Sci; 1984 Mar; 5(1):93-6. PubMed ID: 6735695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy with dialyzable leukocyte extracts and studies of their antigen-specific (transfer factor) activity.
    Fudenberg HH; Wilson GB; Smith CL
    Proc Virchow Pirquet Med Soc; 1980 Dec; 34():3-87. PubMed ID: 6270691
    [No Abstract]   [Full Text] [Related]  

  • 7. Rapidly progressive glomerulonephritis in Behçet's syndrome.
    Landwehr DM; Cooke CL; Rodriguez GE
    JAMA; 1980 Oct; 244(15):1709-11. PubMed ID: 6997523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfer factor therapy in immunodeficiency.
    Griscelli C
    Birth Defects Orig Artic Ser; 1975; 11(1):462-4. PubMed ID: 1148388
    [No Abstract]   [Full Text] [Related]  

  • 9. [Transfer factor (its use in immunotherapy of neoplasms and other diseases)].
    Zduńczyk A
    Wiad Lek; 1980 Jun; 33(11):877-81. PubMed ID: 6999743
    [No Abstract]   [Full Text] [Related]  

  • 10. [Transfer factor immunotherapy of oncological patients].
    Berezhnaia NM; Slinchak SM; Petrovskaia IA; Bezverkhiĭ VD; Kotova SA
    Vopr Onkol; 1981; 27(2):89-91. PubMed ID: 7210602
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical application of transfer factor, lymphokines and thymic factor].
    Hori M
    Nihon Rinsho; 1983; 41(4):857-67. PubMed ID: 6350654
    [No Abstract]   [Full Text] [Related]  

  • 12. [First experience with transfer factor therapy in chronic mucocutaneous candida mycosis].
    Westphal HJ; Kaben U; Schröder I; Jenssen HL; Köhler H; Werner H; Mix E
    Dermatol Monatsschr; 1976 Feb; 162(2):124-8. PubMed ID: 955186
    [No Abstract]   [Full Text] [Related]  

  • 13. [Transfer factor immunotherapy as an adjunct to surgery in lung cancer].
    Fujisawa T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Jan; 23(1):68-73. PubMed ID: 3892117
    [No Abstract]   [Full Text] [Related]  

  • 14. Transfer factor therapy in osteogenic sarcoma.
    Levin AS; Byers VS; Fudenberg HH; Wybran J; Hackett AJ; Johnston JO
    Trans Assoc Am Physicians; 1974; 87():153-8. PubMed ID: 4549141
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-tumor necrotic factor antibody for treatment of neuro-Behçet's disease, a case report.
    Borhani Haghighi A; Safari A
    Clin Neurol Neurosurg; 2008 Mar; 110(3):315-6. PubMed ID: 18053588
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of neuroblastoma with transfer factor (author's transl)].
    Prats J; Padulles J; Español T; García Calderón P; Martínez-Mora J
    An Esp Pediatr; 1976 Nov; 9(8):41-3. PubMed ID: 1015680
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunotherapy of advanced carcinoma maxilla with immunosensitised porcine mesentric lymph node cells with immunospecific xenogenic lymphnode cell transfer factor.
    Jamkar AV
    Indian J Cancer; 1980 Mar; 17(1):25-30. PubMed ID: 7399551
    [No Abstract]   [Full Text] [Related]  

  • 18. [Personal experiences of immunotherapy using the transfer factor].
    D'Amelio R; Franchi F; Aiuti F
    Minerva Med; 1976 May; 67(24):1613-6. PubMed ID: 934516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orally administered specific transfer factor for the treatment of herpes infections.
    Viza D; Vich JM; Phillips J; Rosenfeld F
    Lymphokine Res; 1985; 4(1):27-30. PubMed ID: 4039018
    [No Abstract]   [Full Text] [Related]  

  • 20. Restoration of cell-mediated immune responses with transfer factor.
    Kirkpatrick CH
    Birth Defects Orig Artic Ser; 1975; 11(1):441-4. PubMed ID: 1096989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.